<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Klubthawee N</submitter><funding>Swiss National Science Foundation</funding><pagination>e2101426</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11468357</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(7)</volume><pubmed_abstract>Antimicrobial resistance (AMR) develops when bacteria no longer respond to conventional antimicrobial treatment. The limited treatment options for resistant infections result in a significantly increased medical burden. Antimicrobial peptides offer advantages for treatment of resistant infections, including broad-spectrum activity and lower risk of resistance development. However, sensitivity to proteolytic cleavage often limits their clinical application. Here, a moldable and biodegradable colloidal nano-network is presented that protects bioactive peptides from enzymatic degradation and delivers them locally. An antimicrobial peptide, PA-13, is encapsulated electrostatically into positively and negatively charged nanoparticles made of chitosan and dextran sulfate without requiring chemic</pubmed_abstract><journal>Advanced healthcare materials</journal><pubmed_title>Biopolymer Nano-Network for Antimicrobial Peptide Protection and Local Delivery.</pubmed_title><pmcid>PMC11468357</pmcid><funding_grant_id>200021_184697</funding_grant_id><pubmed_authors>Marco-Dufort B</pubmed_authors><pubmed_authors>Guzzi EA</pubmed_authors><pubmed_authors>Tibbitt MW</pubmed_authors><pubmed_authors>Bovone G</pubmed_authors><pubmed_authors>Aunpad R</pubmed_authors><pubmed_authors>Klubthawee N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biopolymer Nano-Network for Antimicrobial Peptide Protection and Local Delivery.</name><description>Antimicrobial resistance (AMR) develops when bacteria no longer respond to conventional antimicrobial treatment. The limited treatment options for resistant infections result in a significantly increased medical burden. Antimicrobial peptides offer advantages for treatment of resistant infections, including broad-spectrum activity and lower risk of resistance development. However, sensitivity to proteolytic cleavage often limits their clinical application. Here, a moldable and biodegradable colloidal nano-network is presented that protects bioactive peptides from enzymatic degradation and delivers them locally. An antimicrobial peptide, PA-13, is encapsulated electrostatically into positively and negatively charged nanoparticles made of chitosan and dextran sulfate without requiring chemic</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T13:54:40.997Z</modification><creation>2025-04-04T13:54:40.997Z</creation></dates><accession>S-EPMC11468357</accession><cross_references><pubmed>34936732</pubmed><doi>10.1002/adhm.202101426</doi></cross_references></HashMap>